Role of Integrated PET/CT Fusion in Lung Carcinoma
Abstract
Positron emission tomography has emerged as an important diagnostic tool in the management of lung cancers. PET is sensitive
in the detection of lung cancer, but FDG (2-deoxy-2-18uro-D-glucose) is not tumor specic and may accumulate in a variety of
non-malignant conditions occasionally giving false negative result. The addition of CT to PET improves specicity foremost, but
also sensitivity in tumor imaging. Thus, PET/CT fusion images are a more accurate test than either of its individual components
and are probably also better than side-by-side viewing of images from both modalities. PET/CT fusion images are useful in
differentiating between malignant and benign disease, brosis and recurrence, staging and in changing patient management to a
more appropriate therapy. With analysis and discussion, it appears that PET/ CT fusion images have the potential to dramatically
improve our ability to manage the patients with lung cancer and is contributing to our understanding of cancer cell biology and in
the development of new therapies.
Keywords: Positron emission tomography (PET), CAT scan (CT), Lung carcinoma.
in the detection of lung cancer, but FDG (2-deoxy-2-18uro-D-glucose) is not tumor specic and may accumulate in a variety of
non-malignant conditions occasionally giving false negative result. The addition of CT to PET improves specicity foremost, but
also sensitivity in tumor imaging. Thus, PET/CT fusion images are a more accurate test than either of its individual components
and are probably also better than side-by-side viewing of images from both modalities. PET/CT fusion images are useful in
differentiating between malignant and benign disease, brosis and recurrence, staging and in changing patient management to a
more appropriate therapy. With analysis and discussion, it appears that PET/ CT fusion images have the potential to dramatically
improve our ability to manage the patients with lung cancer and is contributing to our understanding of cancer cell biology and in
the development of new therapies.
Keywords: Positron emission tomography (PET), CAT scan (CT), Lung carcinoma.
Joshi, S., Pant, I., Khan, F., Shukla, A., & Gokula, K. (2008). Role of Integrated PET/CT Fusion in Lung Carcinoma. International Journal of Health Sciences, 2(1). Retrieved from https://pub.qu.edu.sa/index.php/journal/article/view/76
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Copyright and license info is not available